Ranbaxy Laboratories
BSE: 500359 | NSE: RANBAXY | ISIN: INE015A01028 | Pharmaceuticals
Competition
| Last Price | Market Cap. (Rs. cr.) |
Sales Turnover |
Net Profit | Total Assets | |
| Sun Pharma | 1,408.30 | 29,168.20 | 3,861.55 | 1,265.29 | 5,175.02 |
| Cipla | 294.40 | 23,638.00 | 5,270.54 | 767.83 | 5,290.99 |
| Dr Reddys Labs | 1,099.85 | 18,559.45 | 4,197.53 | 560.89 | 5,899.40 |
| Ranbaxy Labs | 415.85 | 17,483.06 | 4,494.52 | -1,032.33 | 7,442.15 |
| GlaxoSmithKline | 1,583.00 | 13,408.49 | 1,685.56 | 576.57 | 1,546.72 |
| Lupin | 1,350.25 | 11,873.90 | 2,967.13 | 416.97 | 2,320.21 |
| Piramal Health | 398.50 | 8,329.17 | 2,333.46 | 275.32 | 2,165.88 |
| Cadila Health | 590.90 | 8,065.73 | 1,945.72 | 265.91 | 2,052.70 |
| Divis Labs | 566.10 | 7,401.45 | 1,203.49 | 421.26 | 1,314.44 |
| Glenmark | 232.45 | 6,266.41 | 856.11 | 217.93 | 2,291.33 |




Online









